HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$51.87
Day range
$48.36 - $51.60
Year range
$30.23 - $59.76
Market cap
2.08B USD
Avg Volume
709.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 102.66M | 151.54% |
Operating expense | 103.01M | 75.22% |
Net income | -20.34M | 38.90% |
Net profit margin | -19.81 | 75.71% |
Earnings per share | -0.48 | 42.08% |
EBITDA | -21.73M | 34.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 381.14M | 17.79% |
Total assets | 494.99M | 31.35% |
Total liabilities | 162.38M | 30.32% |
Total equity | 332.61M | — |
Shares outstanding | 42.21M | — |
Price to book | 6.58 | — |
Return on assets | -11.14% | — |
Return on capital | -13.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -20.34M | 38.90% |
Cash from operations | -29.39M | -104.02% |
Cash from investing | -51.70M | -27.59% |
Cash from financing | 1.95M | -95.39% |
Net change in cash | -79.14M | -527.59% |
Free cash flow | -23.85M | -660.80% |
About
Founded
2016
Headquarters
Website
Employees
323
